Some stem cell therapies would skip usual FDA rules under new guidelines – Philly.com
Philly.com |
Some stem cell therapies would skip usual FDA rules under new guidelines
Philly.com But the new guidance, put out as a draft in 2014, does not address the explosion of stem cell clinics offering treatments that may be ineffective or worse. Some clinics charge thousands of dollars to suck out and then inject cells taken from the … |
